4.7 Article

Frequency tuning allows flow direction control in microfluidic networks with passive features

Journal

LAB ON A CHIP
Volume 17, Issue 9, Pages 1552-1558

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c7lc00058h

Keywords

-

Funding

  1. U.S. National Science Foundation [1231396]
  2. Directorate For Engineering
  3. Div Of Electrical, Commun & Cyber Sys [1231396] Funding Source: National Science Foundation

Ask authors/readers for more resources

Frequency tuning has emerged as an attractive alternative to conventional pumping techniques in microfluidics. Oscillating (AC) flow driven through a passive valve can be rectified to create steady (DC) flow, and tuning the excitation frequency to the characteristic (resonance) frequency of the underlying microfluidic network allows control of flow magnitude using simple hardware, such as an on-chip piezo buzzer. In this paper, we report that frequency tuning can also be used to control the direction (forward or backward) of the rectified DC flow in a single device. Initially, we observed that certain devices provided DC flow in the forward direction expected from previous work with a similar valve geometry, and the maximum DC flow occurred at the same frequency as a prominent peak in the AC flow magnitude, as expected. However, devices of a slightly different geometry provided the DC flow in the opposite direction and at a frequency well below the peak AC flow. Using an equivalent electrical circuit model, we found that the forward DC flow occurred at the series resonance frequency (with large AC flow peak), while the backward DC flow occurred at a less obvious parallel resonance (a valley in AC flow magnitude). We also observed that the DC flow occurred only when there was a measurable differential in the AC flow magnitude across the valve, and the DC flow direction was from the channel with large AC flow magnitude to that with small AC flow magnitude. Using these observations and the AC flow predictions from the equivalent circuit model, we designed a device with an AC flowrate frequency profile that was expected to allow the DC flow in opposite directions at two distinct frequencies. The fabricated device showed the expected flow reversal at the expected frequencies. This approach expands the flow control toolkit to include both magnitude and direction control in frequency-tuned microfluidic pumps. The work also raises inter-esting questions about the origin of flow reversal behavior that may be addressed by the further study of the circuit model behavior or dynamic modeling of the fluid-solid mechanics of the valve under the AC flow.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

URINE BIOMARKER ASSESSMENT OF INFANT ADHERENCE TO ISONIAZID PROPHYLAXIS

Sylvia M. LaCourse, Daniel Leon, Nuttada Panpradist, Barbra A. Richardson, Elizabeth Maleche-Obimbo, Jerphason Mecha, Daniel Matemo, Jaclyn N. Escudero, John Kinuthia, Barry Lutz, Grace John-Stewart

Summary: In an infant tuberculosis prevention trial in Kenya, urine isoniazid metabolite-detecting dipsticks were used to assess adherence. Positive test results were associated with maternal secondary education, HIV suppression, and no reported missed doses in the past 3 days, suggesting caregiver education and self-medication influenced infant adherence.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)

Article Cell Biology

Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State

Nicola F. Mueller, Cassia Wagner, Chris D. Frazar, Pavitra Roychoudhury, Jover Lee, Louise H. Moncla, Benjamin Pelle, Matthew Richardson, Erica Ryke, Hong Xie, Lasata Shrestha, Amin Addetia, Victoria M. Rachleff, Nicole A. P. Lieberman, Meei-Li Huang, Romesh Gautom, Geoff Melly, Brian Hiatt, Philip Dykema, Amanda Adler, Elisabeth Brandstetter, Peter D. Han, Kairsten Fay, Misja Llcisin, Kristen Lacombe, Thomas R. Sibley, Melissa Truong, Caitlin R. Wolf, Michael Boeckh, Janet A. Englund, Michael Famulare, Barry R. Lutz, Mark J. Rieder, Matthew Thompson, Jeffrey S. Duchin, Lea M. Starita, Helen Y. Chu, Jay Shendure, Keith R. Jerome, Scott Lindquist, Alexander L. Greninger, Deborah A. Nickerson, Trevor Bedford

Summary: The study analyzed the spread of SARS-CoV-2 in Washington State in early 2020, finding that factors influencing transmission included the timing of mitigation measures and repeated introductions of viral lineages. Additionally, the increase in frequency of the 614G variant may be related to regional mobility differences and multiple introductions, but no evidence was found that this variant affects clinical severity or patient outcomes.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Correction Medicine, General & Internal

Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays (vol 64, 103236, 2021)

Nuttada Panpradist, Qin Wang, Parker S. Ruth, Jack H. Kotnik, Amy K. Oreskovic, Abraham Miller, Samuel W. A. Stewart, Justin Vrana, Peter D. Han, Ingrid A. Beck, Lea M. Starita, Lisa M. Frenkel, Barry R. Lutz

EBIOMEDICINE (2021)

Article Infectious Diseases

Characterizing the molecular composition and diagnostic potential of Mycobacterium tuberculosis urinary cell-free DNA using next-generation sequencing

Amy Oreskovic, Adam Waalkes, Elizabeth A. Holmes, Christopher A. Rosenthal, Douglas P. K. Wilson, Adrienne E. Shapiro, Paul K. Drain, Barry R. Lutz, Stephen J. Salipante

Summary: This study characterized the size and composition of urine cell-free DNA from tuberculosis patients using next-generation sequencing, finding that MTB cfDNA is shorter and increases in abundance with shorter fragment lengths. Additionally, a larger fraction of short human genomic cfDNA was identified in urine samples, along with cfDNA fragments spanning the MTB genome.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Health Care Sciences & Services

Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial

Sarah Iribarren, Hannah Milligan, Kyle Goodwin, Omar Alfonso Aguilar Vidrio, Cristina Chirico, Hugo Telles, Daniela Morelli, Barry Lutz, Jennifer Sprecher, Fernando Rubinstein

Summary: This study aims to evaluate the effectiveness of a TB treatment support tool intervention on treatment outcomes and assess patient and provider perceptions of the facilitators and barriers to implementation. The intervention includes a smartphone app, treatment supporter, and a home-based adherence test strip, with the hypothesis that it will be more effective in improving outcomes. Data collection is expected to be completed by 2022, with results to be published within a year, providing evidence on the adoption of mobile health tools and broader implications for chronic disease management.

JMIR RESEARCH PROTOCOLS (2021)

Article Immunology

Rapid Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir

Jackson J. Wallner, Ingrid A. Beck, Nuttada Panpradist, Parker S. Ruth, Humberto Valenzuela-Ponce, Maribel Soto-Nava, Santiago Avila-Rios, Barry R. Lutz, Lisa M. Frenkel

Summary: An inexpensive and easy-to-use rapid assay for detecting HLA-B*57:01 was developed in this study, which is of great significance for patients with HIV infection using ABC treatment.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)

Article Chemistry, Analytical

Isothermal Amplification with a Target-Mimicking Internal Control and Quantitative Lateral Flow Readout for Rapid HIV Viral Load Testing in Low-Resource Settings

Ian T. Hull, Enos C. Kline, Gaurav K. Gulati, Jack Henry Kotnik, Nuttada Panpradist, Kamal G. Shah, Qin Wang, Lisa Frenkel, James Lai, Joanne Stekler, Barry R. Lutz

Summary: The study presents a novel quantitative detection method for HIV DNA or RNA using a combination of recombinase polymerase amplification and lateral flow detection technologies, allowing for rapid and accurate testing in low-resource healthcare settings, with the potential to improve the quality of HIV treatment.

ANALYTICAL CHEMISTRY (2022)

Review Microbiology

Requirements and Study Designs for US Regulatory Approval of Influenza Home Tests

Tony Yang, Larry G. Kessler, Matthew J. Thompson, Barry R. Lutz

Summary: Home testing for infectious diseases, including COVID-19, has gained significant attention and commercial interest. However, the regulatory science and procedures for approval of home infectious disease tests have not yet been formalized by the FDA. This article discusses the state of home-based testing for influenza, regulatory pathways for market access, and provides recommendations for study designs and other important features.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

Article Multidisciplinary Sciences

Harmony COVID-19: A ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection

Nuttada Panpradist, Enos C. Kline, Robert G. Atkinson, Michael Roller, Qin Wang, Ian T. Hull, Jack H. Kotnik, Amy K. Oreskovic, Crissa Bennett, Daniel Leon, Victoria Lyon, Shane D. Gilligan-Steinberg, Peter D. Han, Paul K. Drain, Lea M. Starita, Matthew J. Thompson, Barry R. Lutz

Summary: The Harmony COVID-19 test offers a cost-effective and user-friendly solution for detecting SARS-CoV-2 infection, with a high success rate and accuracy, as demonstrated through clinical evaluations and usability testing.

SCIENCE ADVANCES (2021)

Article Chemistry, Analytical

Aptamer Sandwich Lateral Flow Assay (AptaFlow) for Antibody-Free SARS-CoV-2 Detection

Lucy F. Yang, Nataly Kacherovsky, Nuttada Panpradist, Ruixuan Wan, Joey Liang, Bo Zhang, Stephen J. Salipante, Barry R. Lutz, Suzie H. Pun

Summary: In this study, researchers identified a new DNA aptamer (SNAP4) that binds with high affinity to the SARS-CoV-2 spike protein. AptaFlow, a lateral flow assay using both SNAP1 and SNAP4, was able to detect UV-inactivated SARS-CoV-2 virus at concentrations as low as 106 copies/mL.

ANALYTICAL CHEMISTRY (2022)

Article Microbiology

Multiplex Target-Redundant RT-LAMP for Robust Detection of SARS-CoV-2 Using Fluorescent Universal Displacement Probes

Enos C. Kline, Nuttada Panpradist, Ian T. Hull, Qin Wang, Amy K. Oreskovic, Peter D. Han, Lea M. Starita, Barry R. Lutz

Summary: During the COVID-19 pandemic, the prevalence of variant lineages has the potential to disrupt molecular diagnostics. To address this challenge, a robust Loop Mediated Isothermal Amplification assay with multiplexed multitarget redundancy and an internal amplification control was developed. The assay showed high coverage and sensitivity, making it a valuable tool in point-of-care molecular diagnostics.

MICROBIOLOGY SPECTRUM (2022)

Article Health Care Sciences & Services

Patient-centered mobile tuberculosis treatment support tools (TB-TSTs) to improve treatment adherence: A pilot randomized controlled trial exploring feasibility, acceptability and refinement needs

Sarah J. Iribarren, Hannah Milligan, Cristina Chirico, Kyle Goodwin, Rebecca Schnall, Hugo Telles, Alejandra Iannizzotto, Myrian Sanjurjo, Barry R. Lutz, Kenneth Pike, Fernando Rubinstein, Marcus Rhodehamel, Daniel Leon, Jesse Keyes, George Demiris

Summary: This study explored the acceptability, feasibility, and refinement needs of a TB Treatment Support Tools intervention. The results showed that the intervention was feasible and acceptable, and further improvements and testing are necessary.

LANCET REGIONAL HEALTH-AMERICAS (2022)

Article Chemistry, Analytical

Simultaneous monitoring of HIV viral load and screening of SARS-CoV-2 employing a low-cost RT-qPCR test workflow

Gaurav K. Gulati, Nuttada Panpradist, Samuel W. A. Stewart, Ingrid A. Beck, Ceejay Boyce, Amy K. Oreskovic, Claudia Garcia-Morales, Santiago Avila-Rios, Peter D. Han, Gustavo Reyes-Teran, Lea M. Starita, Lisa M. Frenkel, Barry R. Lutz, James J. Lai

Summary: The COVID-19 pandemic has disrupted routine care for HIV patients, increasing the risk of virologic failure and HIV-related illnesses. A non-proprietary method has been developed to extract RNA from plasma and nasal secretions, allowing for the estimation of viral load and classification of HIV/SARS-CoV-2 status. The in-house RNA extraction workflow has shown high consistency with standard extraction methods in contrived samples and clinical specimens. This low-cost molecular test workflow can serve as an alternative to current standard assays in low-resource settings.

ANALYST (2022)

Article Medicine, General & Internal

Fluidic Considerations of Measuring Intracranial Pressure Using an Open External Ventricular Drain

Peter G. Beidler, Alexander Novokhodko, Laura M. Prolo, Samuel Browd, Barry R. Lutz

Summary: This study investigates the fluidic sources of error for ICP measurement with concurrent drainage in an EVD, showing that the error in pressure measurement increases linearly with flow rate but is not clinically significant. The predicted maximum error from fluidic effects within the drainage system is small compared to other sources of error in current ICP monitoring, allowing for clinical use.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Article Computer Science, Information Systems

The Design and Evaluation of a Mobile System for Rapid Diagnostic Test Interpretation

Chunjong Park, Hung Ngo, Libby Rose Lavitt, Vincent Karuri, Shiven Bhatt, Peter Lubell-Doughtie, Anuraj H. Shankar, Leonard Ndwiga, Victor Osoti, Juliana K. Wambua, Philip Bejon, Lynette Isabella Ochola-Oyier, Monique Chilver, Nigel Stocks, Victoria Lyon, Barry R. Lutz, Matthew Thompson, Alex Mariakakis, Shwetak Patel

Summary: RDTScan is a system designed for detecting and interpreting lateral flow RDTs using a smartphone, providing real-time guidance for clear image capture and automatic interpretation for accurate diagnostic decisions. Through field evaluations, RDTScan achieved high accuracy rates in at-home influenza testing in Australia and malaria testing by community healthcare workers in Kenya compared to expert interpretation of RDTs.

PROCEEDINGS OF THE ACM ON INTERACTIVE MOBILE WEARABLE AND UBIQUITOUS TECHNOLOGIES-IMWUT (2021)

No Data Available